This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by van Engelen, B. G. Articles by Rodriguez, M. Search for Related Content PubMed PubMed Citation Articles by van Engelen, B. G. Articles by Rodriguez, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Social Bookmarking                         What's this?

Enhancement of central nervous system remyelination in immune and non-immune experimental models of demyelination

Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA, Immunology, Mayo Clinic, Rochester, Minnesota, USA, Institute of Neurology, University Hospital Nijmegen, The Netherlands

Kevin D Pavelko

Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA, Immunology, Mayo Clinic, Rochester, Minnesota, USA

Moses Rodriguez

Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA, Immunology, Mayo Clinic, Rochester, Minnesota, USA

Studies in both humans and experimental animals indicate that there is potential for full remyelination following CNS demyelination, but the factors that control the degree of myelin repair are unknown. In the Theiler's virus model of demyelination CNS remyelination can be promoted either by global immunosuppression or by selective immunoglobulin therapy. In this paper we discuss whether immunoglobulin-mediated remyelination is a characteristic of immune-mediated demyelination, or whether immunoglobulin-mediated remyelination also occurs in the toxic-traumatic model of lysolecithin-induced demyelination. Our data support the hypothesis that even in a non-primary immune model of demyelination, manipulating the immune system can be beneficial in myelin repair.

Key Words: remyelination • demyelination • CNS • experimental models • humans • immunoglobulin

Multiple Sclerosis, Vol. 3, No. 2, 76-79 (1997)
DOI: 10.1177/135245859700300203


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S Adler, J Martinez, D S Williams, and J G Verbalis Positive association between blood brain barrier disruption and osmotically-induced demyelination Multiple Sclerosis, February 1, 2000; 6(1): 24 - 31. [Abstract] [PDF]